The Mycobiota: Its Role in Health and Disease

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".

Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 2795

Special Issue Editor


E-Mail Website
Guest Editor
Department of Public Health and Pediatrics, Microbiology Division, University of Turin, 10126 Turin, Italy
Interests: bacteriological and mycological diagnostics; antimicrobial agents (antibiotics, essential oils, etc.) in vitro activity towards bacteria, yeasts, and filamentous mycetes; immunomodulatory activity of antibiotics and essential oils on the phagocyte–pathogen binomial, studying phagocytosis, intracellular killing, and citokynes release; antimicrobial activity of drug oxygen free/loaded delivery systems (nanodroplets, nanoparticles, nanobubbles, etc.); influence of probiotics on gut microbiome in infant
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Current studies have documented that, like bacteria, diverse populations of fungi are characteristic to specific sites. Commensal fungi residing in the human and animal body—the mycobiota—are critical components of health and disease: Although they are generally considered to be a minor component, they can have profound effects on the immune system. Disruption of the mycobiota has been proposed to influence the course of infectious diseases, especially among immunocompromised patients (e.g., HIV-infected or cancer patients). 

It is known that the distribution and profile of fungal species in healthy individuals is complex with respect to the number of species identified. For example, the presence of AspergillusFusarium, and Cryptococcus isolates in the oral cavity of healthy individuals is unexpected, since these fungi have not been reported to be colonizers of the oral cavity: It is possible that their pathogenicity is controlled in healthy individuals by other fungi in the oral mycobiota, as well as a functional immune system. It is possible that interdependent relationships may exist between components of the mycobiota and need to be investigated. 

The aim of this Special Issue is to understand the role and the interactions between mycobiota components and the host, both human and animal. Since commensal fungal population vary between body sites, over time and with diseases, it will be interesting to know changes in fungal populations that occur together with pathologies at various sites (skin, hair and nails, oral cavity and gut, vagina, lung) and how the immune system interacts with specific fungi in healthy and disease states. Understanding the relationships between fungal species and other members of the mycobiota will shed light on the pathogenicity of these organisms and may lead to the discovery of novel therapeutic approaches for the prevention and treatment of fungal diseases

Prof. Dr. Vivian Tullio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • commensal fungi
  • mycobiota
  • body sites
  • role in fungal diseases
  • immune system
  • novel therapeutic approaches

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

11 pages, 1378 KiB  
Review
Anti-Infective Antibody-Derived Peptides Active against Endogenous and Exogenous Fungi
by Tecla Ciociola, Laura Giovati, Stefania Conti and Walter Magliani
Microorganisms 2021, 9(1), 143; https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms9010143 - 10 Jan 2021
Cited by 7 | Viewed by 2027
Abstract
Mycoses still represent relevant opportunistic infections worldwide, although overshadowed in recent years by other severe and more widespread infections. Moreover, deep-seated mycoses are often accompanied by unacceptably high mortality rates. Etiologic agents include endogenous components of the mycobiota, Candida and Malassezia species above [...] Read more.
Mycoses still represent relevant opportunistic infections worldwide, although overshadowed in recent years by other severe and more widespread infections. Moreover, deep-seated mycoses are often accompanied by unacceptably high mortality rates. Etiologic agents include endogenous components of the mycobiota, Candida and Malassezia species above all, and exogenous species, both yeasts and filamentous fungi. Old and new fungal pathogens are increasingly characterized by resistance to the existing antifungal agents, making imperative the search for effective and safe new therapeutics. Among the candidate molecules proposed in recent decades, synthetic peptides derived from the complementarity determining and constant regions of diverse antibodies (Abs), as well as the translated products of Ab-encoding genes, have proved of considerable interest. Their anti-infective activities, regardless of the specificity and isotype of the originating Ab, will be briefly presented and discussed in the light of their different mechanisms of action. Intriguing suggestions on the possible function of Abs after their half-life will be presented, following the recent detection, in human serum, of an antimicrobial Ab-derived peptide. Overall, Abs could represent a source of biologically active, highly flexible peptides, devoid of detectable toxicity, which can be easily synthesized and manipulated to be used, alone or in association with already available drugs, for new anti-infective strategies. Full article
(This article belongs to the Special Issue The Mycobiota: Its Role in Health and Disease)
Show Figures

Figure 1

Back to TopTop